title: [Information content of medication schedules prior to the implementation of the federal standard medication plan].
abstract: BACKGROUND
  Polypharmacy and complex medication regimens are challenging in patient care. Written information like a medication schedule is the main component in this context. To exchange these data the federal medication plan is an adequate medium. However there is insufficient knowledge of whether structures for implementation exist and which categories are already used in daily practice. It is also unknown how often an update for these schedules is necessary.
  
  
  METHODS
  During a medication review including a brown-bag analysis the current medication from 500 patients was assessed and compared to the medication schedule available. In this way we established both the categories of the federal medication plan that are already in use and the age of the plan. Age and frequency of data within the different categories were compared to the number of deviations. In addition, these data were analyzed for different authorships.
  
  
  RESULTS
  None of the 399 medication schedules fully complied with the draft. The brand name was listed in only 33.8 %, but with large deviations (41 %) from the currently used brand. Brand names and the name of the active component were used in a mixed manner. Dosage was missing in 34.6 % of the medications, and in 80.2 % the formulations were not provided. Indication was lacking in 95.2 % of the medications and intake recommendations in 96.7 %. Large differences were seen with different authors. The average age of the plans was 4.5 months [range 0-12 months]. The number of discrepancies increased by 50 % after two months, statistical significance was reached after 4.5 months (p=0.039).
  
  
  CONCLUSIONS
  The complete categories of the federal medication plan are not commonly used in everday practice. Essential information such as the correct brand name, dosages and intake recommendations as well as medication relevant safety data concerning galenic form and indication is not fully provided. To achieve implementation and completeness of medication plans, interprofessional collaboration of all healthcare professions with the involvement of patients is reasonable. Updating is necessary after each change in medication but should also be routinely conducted every 3 months.
authors.affiliation: Westfälische Wilhelms-Universität, Institut für Pharmazeutische und Medizinische Chemie, Klinische Pharmazie, Münster, Deutschland. Electronic address: i.waltering@uni-muenster.de.
authors.forename: Isabel
authors.initials: I
authors.lastname: Waltering
authors.affiliation: Apothekerkammer Westfalen-Lippe, Abteilung Aus- und Fortbildung und Arzneimitteltherapiesicherheit, Münster, Deutschland.
authors.forename: Oliver
authors.initials: O
authors.lastname: Schwalbe
authors.affiliation: Westfälische Wilhelms-Universität, Institut für Pharmazeutische und Medizinische Chemie, Klinische Pharmazie, Münster, Deutschland.
authors.forename: Georg
authors.initials: G
authors.lastname: Hempel
mesh_terms: D003625:Data Collection; D016208:Databases, Factual; D017723:Drug Utilization Review; D005858:Germany; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D059065:Medication Reconciliation / Q000706:statistics & numerical data*; D019338:Polypharmacy
keywords: Arzneimitteltherapiesicherheit; Bundeseinheitlicher Medikationsplan; E-Health-Gesetz; Medikationsanalyse; Polypharmazie; community pharmacy; e-health law; medication review; medication schedule; polypharmacy; safety of medication therapy; öffentliche Apotheke